CLDN7 and hepatocellular carcinoma: Immunohistochemical investigations have identified attenuated expression of CLAUDIN-1 as a potential marker for poor prognosis in poorly differentiated HCC [27], suggestive of tumor suppressive effects of CLAUDIN-1 in HCC.